-
•
All STEMI patients should initially undergo evaluation in the ED.
-
•
Patients should be evaluated in the ED prior to CCL activation to ensure appropriate risks are assessed.
-
•
All patients require the placement of a face mask to prevent droplet contamination of the CCL and environment prior to transport.
|
-
•
CCL staff and physicians should have appropriate PPE for safe performance of the procedure, including gowns, gloves, full face mask, and an N95 respiratory mask. If N95 masks are to be reused between cases by a single HCW, then an additional surgical mask should be worn on top of this mask. The number of HCWs present during the procedure should be limited to only those essential for patient care and procedure support.
|
-
•
Patients with respiratory compromise should be intubated prior to arrival in the CCL if possible.
-
•
If intubation is required in the CCL, all personnel should have complete PPE and exposures should be minimized to essential team members only.
-
•
For all procedures at high risk of aerosolization, PAPRs should be considered.
|
|
|
-
•
During the COVID-19 period, there may be delays in D2B times that result from evaluation and/or management of COVID-19 patients. This can be documented in the medical record and coded in the NCDR CathPCI version 5 as follows:
-
•
If primary PCI for STEMI, code “Yes” for Seq. #7850 (patient-centered reason for delay in PCI) and selecting “Other” in Seq. #7851 (delay reason).
-
•
If primary thrombolytic therapy for STEMI, code “Yes” for Seq. #14208 (patient reason for delay in thrombolytic).
|
|
|